- November 17, 2019
- Category: Energy and Power, Power Generation and Storage
Global Soft Tissue Allografts Market Size study, by Type (Cartilage Allograft, Tendon Allograft, Meniscus Allograft, Dental Allograft, Others), by Application (Orthopedic, Dentistry, Wound Care, Others), by End-User (Hospitals, Aesthetic Centers, Orthopedic Clinics, Dental Clinics, Others) and Regional Forecasts 2020-2026
Chapter 1. Executive Summary 1.1. Market Snapshot 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion) 1.2.1. Soft Tissue Allografts Market, by Region, 2018-2026 (USD Billion) 1.2.2. Soft Tissue Allografts Market, by Type, 2018-2026 (USD Billion) 1.2.3. Soft Tissue Allografts Market, by Application, 2018-2026 (USD Billion) 1.2.4. Soft Tissue Allografts Market, by End-User, 2018-2026 (USD Billion) 1.3. Key Trends 1.4. Estimation Methodology 1.5. Research Assumption Chapter 2. Global Soft Tissue Allografts Market Definition and Scope 2.1. Objective of the Study 2.2. Market Definition & Scope 2.2.1. Scope of the Study 2.2.2. Industry Evolution 2.3. Years Considered for the Study 2.4. Currency Conversion Rates Chapter 3. Global Soft Tissue Allografts Market Dynamics 3.1. Soft Tissue Allografts Market Impact Analysis (2018-2026) 3.1.1. Market Drivers 3.1.2. Market Challenges 3.1.3. Market Opportunities Chapter 4. Global Soft Tissue Allografts Market Industry Analysis 4.1. Porterâ€™s 5 Force Model 4.1.1. Bargaining Power of Suppliers 4.1.2. Bargaining Power of Buyers 4.1.3. Threat of New Entrants 4.1.4. Threat of Substitutes 4.1.5. Competitive Rivalry 4.1.6. Futuristic Approach to Porterâ€™s 5 Force Model (2016-2026) 4.2. PEST Analysis 4.2.1. Political 4.2.2. Economical 4.2.3. Social 4.2.4. Technological 4.3. Investment Adoption Model 4.4. Analyst Recommendation & Conclusion Chapter 5. Global Soft Tissue Allografts Market, by Type 5.1. Market Snapshot 5.2. Global Soft Tissue Allografts Market by Type, Performance - Potential Analysis 5.3. Global Soft Tissue Allografts Market Estimates & Forecasts by Type 2016-2026 (USD Billion) 5.4. Soft Tissue Allografts Market, Sub Segment Analysis 5.4.1. Cartilage Allograft 5.4.2. Tendon Allograft 5.4.3. Meniscus Allograft 5.4.4. Dental Allograft 5.4.5. Others Chapter 6. Global Soft Tissue Allografts Market, by Application 6.1. Market Snapshot 6.2. Global Soft Tissue Allografts Market by Application, Performance - Potential Analysis 6.3. Global Soft Tissue Allografts Market Estimates & Forecasts by Application 2016-2026 (USD Billion) 6.4. Soft Tissue Allografts Market, Sub Segment Analysis 6.4.1. Orthopedic 6.4.2. Dentistry 6.4.3. Wound Care 6.4.4. Others Chapter 7. Global Soft Tissue Allografts Market, by End-User 7.1. Market Snapshot 7.2. Global Soft Tissue Allografts Market by End-User, Performance - Potential Analysis 7.3. Global Soft Tissue Allografts Market Estimates & Forecasts by End-User 2016-2026 (USD Billion) 7.4. Soft Tissue Allografts Market, Sub Segment Analysis 7.4.1. Hospitals 7.4.2. Aesthetic Centers 7.4.3. Orthopedic Clinics 7.4.4. Dental Clinics 7.4.5. Others Chapter 8. Global Soft Tissue Allografts Market, Regional Analysis 8.1. Soft Tissue Allografts Market, Regional Market Snapshot 8.2. North America Soft Tissue Allografts Market 8.2.1. U.S. Soft Tissue Allografts Market 126.96.36.199. Type breakdown estimates & forecasts, 2016-2026 188.8.131.52. Application breakdown estimates & forecasts, 2016-2026 184.108.40.206. End-User breakdown estimates & forecasts, 2016-2026 8.2.2. Canada Soft Tissue Allografts Market 8.3. Europe Soft Tissue Allografts Market Snapshot 8.3.1. U.K. Soft Tissue Allografts Market 8.3.2. Germany Soft Tissue Allografts Market 8.3.3. Rest of Europe Soft Tissue Allografts Market 8.4. Asia-Pacific Soft Tissue Allografts Market Snapshot 8.4.1. China Soft Tissue Allografts Market 8.4.2. India Soft Tissue Allografts Market 8.4.3. Japan Soft Tissue Allografts Market 8.4.4. Rest of Asia Pacific Soft Tissue Allografts Market 8.5. Latin America Soft Tissue Allografts Market Snapshot 8.5.1. Brazil Soft Tissue Allografts Market 8.5.2. Mexico Soft Tissue Allografts Market 8.6. Rest of The World Soft Tissue Allografts Market Chapter 9. Competitive Intelligence 9.1. Top Market Strategies 9.2. Company Profiles 9.2.1. Allergan Plc 220.127.116.11. Key Information 18.104.22.168. Overview 22.214.171.124. Financial (Subject to Data Availability) 126.96.36.199. Type Summary 188.8.131.52. Recent Developments 9.2.2. B. Braun Melsungen AG 9.2.3. CONMED Corporation 9.2.4. Xtant Medical Holdings, Inc. 9.2.5. Alliqua BioMedical, Inc. 9.2.6. AlonSource Group 9.2.7. Becton Dickinson and Company 9.2.8. Arthrex, Inc. 9.2.9. Bone Bank Allografts 9.2.10. Integra LifeSciences Corporation Chapter 10. Research Process 10.1. Research Process 10.1.1. Data Mining 10.1.2. Analysis 10.1.3. Market Estimation 10.1.4. Validation 10.1.5. Publishing 10.2. Research Attributes 10.3. Research Assumption
Global Soft Tissue Allografts Market is valued approximately USD 4.0 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 7.0% over the forecast period 2020-2026. Soft tissue allografts are a type of substitute tissues used in reconstruction of deficient ligaments, torn menisci, spinal surgeries and osteochondral defects during knee surgeries. Soft tissue allografts have required to undergo a safety screening process in three stages that include donor screening, laboratory testing, and tissue preparation. The use of these allografts has a latent for disease transmission, delayed graft incorporation and host versus donor immunologic reaction to the graft. Further, these allografts are majorly made up of skin, tendons, veins, cartilage and heart valves, and are used for transplant in distinct forms of surgeries. Rise in the incidences of degenerative joint disorders, growing number of the elderly population and escalating demand for soft tissue allografts among athletic patients are the few factors responsible for high CAGR of the market over the forecast period. As per the report published by the Transplant Department of Cleveland Clinic, there were around 30,000 surgeries with allograft tissue are performed every year in the clinics including, meniscal transplants and anterior cruciate ligament procedures. Similarly, as per the World Health Organization (WHO), degenerative joint diseases affect 18.0% women and 9.6% men aged above 60 years with symptomatic osteoarthritis. This, in turn, is expected to accelerate the demand for soft tissue allografts, thus contributing to the growth of the global market. However, thehigh cost of the treatment, aided with unfavorable reimbursement policies are the few factors expected to hamper the growth of the market over the forecast period of 2020-2026.
The regional analysis of global Soft Tissue Allografts market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the surging prevalence of diabetic foot ulcers, presence of healthcare awareness program for diseases and rise in number of surgical procedures on anterior cruciate ligament (ACL) in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026, due to increase in number of tissue banks and growing aging population in the countries like China and India.
Major market player included in this report are:
B. Braun Melsungen AG
Xtant Medical Holdings, Inc.
Alliqua BioMedical, Inc.
Becton Dickinson and Company
Bone Bank Allografts
Integra LifeSciences Corporation
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year â€“ 2016, 2017, 2018
Base year â€“ 2019
Forecast period â€“ 2020 to 2026
Target Audience of the Global Soft Tissue Allografts Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Value-Added Resellers (VARs)
Third-party knowledge providers